This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jms Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ayaka Yamamoto: Innovator in Synthetic Resin Stents
Introduction
Ayaka Yamamoto is a notable inventor based in Hiroshima, Japan. She has made significant contributions to the field of medical devices, particularly in the development of synthetic resin stents. Her innovative approach has the potential to enhance the effectiveness and reliability of stents used in various medical applications.
Latest Patents
Ayaka Yamamoto holds a patent for a synthetic resin stent. This stent is designed to ensure storability in thin tubular members, such as delivery systems, and is resistant to positional displacement after placement in an affected part of a bodily conduit. The synthetic resin comprises a tubular first braid component made of a plurality of fibers braided into a net-like form, along with a second braid component that forms an annular shape. The design includes various fibers and intersections that enhance the stent's functionality and stability.
Career Highlights
Throughout her career, Ayaka Yamamoto has focused on advancing medical technology through her innovative designs. Her work has been recognized for its potential to improve patient outcomes and streamline medical procedures. She is currently associated with Jms Co., Ltd., where she continues to develop cutting-edge medical devices.
Collaborations
Ayaka collaborates with Shuji Fukutaki, who is also involved in the field of medical innovations. Their partnership exemplifies the importance of teamwork in driving advancements in technology and healthcare.
Conclusion
Ayaka Yamamoto's contributions to the field of synthetic resin stents highlight her innovative spirit and dedication to improving medical technology. Her work not only showcases her expertise but also has the potential to make a significant impact on patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
